Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-09

FDA Approved: LEVOCARNITINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves the original (generic) application for levocarnitine from ANI Pharmaceuticals, Inc., making a generic version of levocarnitine available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOCARNITINE (levocarnitine)

Snippet

ORIG AP for LEVOCARNITINE (LEVOCARNITINE)